Drop in ED visits, admissions seen in hospitals targeted by ransomware
May 30, 2024
A transient decrease was seen, with a return to preattack levels within eight weeks; an increase was seen in emergency department visits at nearby hospitals.
Assisted living providers must pay attention to Medicaid beneficiary protections in HCBS regulations,...
By
Kimberly Bonvissuto
Oct 13, 2023
Assisted living providers might be breaking state and federal laws in refusing to accept Medicaid or in attempting to evict residents without giving them an opportunity to appeal, according to two elder...
Physical activity may cut heart failure risk in women
Feb 23, 2024
The findings were seen for overall accelerometer-measured physical activity and light or moderate-to-vigorous activity, as well as for steps per day.
Reduced cancer risk seen after 10 years since quitting smoking
Feb 08, 2024
After 15 or more years since quitting, the cancer risk reached 50% of that associated with continued smoking.
Whole grain consumption linked to slower global cognitive decline
Nov 22, 2023
For African Americans, those in the highest quintile of whole grain consumption had slower declines in global cognition, perceptual speed and episodic memory.
Food insecurity in seniors linked to increased risk for dementia
Nov 21, 2023
Lower memory levels and faster age-related memory decline also were seen in association with low or very low food security.
Time-restricted eating effective for weight loss, lowering HbA1c
Nov 02, 2023
TRE without calorie counting is effective and yields significant reduction in body weight at six months.
Severe QT prolongation common in users of antipsychotic medications
Jan 23, 2024
For severe QT prolongation, common risk factors included old age, heart failure, hypokalemia, amiodarone use and baseline QTc interval.
Improvements in acute, subacute low back pain seen within first six weeks
Jan 22, 2024
Based on very low-certainty evidence, individuals with persistent low back pain have minimal improvements over time.
Simnotrelvir shortens time to resolution of symptoms in COVID-19
Jan 18, 2024
On day 5, the decrease in viral load from baseline was greater in the simnotrelvir group versus the placebo group.